Biotechnology Value Fund, L.P. et al v. Celera Corporporation et al

Filing 172

ORDER SETTING BRIEFING SCHEDULE AND HEARING ON 169 NON-PARTY PHARMACYCLICS INC.'S MOTION TO QUASH. Signed by Judge Alsup on 9/16/2014. (whalc2, COURT STAFF) (Filed on 9/16/2014).

1
2
3
4
5
6

IN THE UNITED STATES DISTRICT COURT

7
FOR THE NORTHERN DISTRICT OF CALIFORNIA
8
9

11
For the Northern District of California

United States District Court

10

12

BIOTECHNOLOGY VALUE FUND, L.P.,
BIOTECHNOLOGY VALUE FUND II,
L.P., INVESTMENT 10, L.L.C., BVF
INVESTMENTS, L.L.C.; BVF INC., and
BVF X, LLC,

13
14
15
16
17
18
19

Plaintiffs,
v.
CELERA CORPORATION, CREDIT
SUISSE SECURITIES (USA) LLC,
KATHY ORDOÑEZ, RICHARD H.
AYERS, WILLIAM G. GREEN, PETER
BARTON HUTT, GAIL M. NAUGHTON,
WAYNE I. ROE, and BENNETT M.
SHAPIRO,

No. C 13-03248 WHA

ORDER SETTING
BRIEFING SCHEDULE AND
HEARING ON NON-PARTY
PHARMACYCLICS INC.’S
MOTION TO QUASH

Defendants.
/

20
21

Pursuant to the order dated September 11, 2014, non-party Pharmacyclics Inc. has filed a

22

motion to quash plaintiffs’ subpoena for certain drug valuation documents. However, given that

23

the discovery cut-off is October 21, 2014, this order hereby schedules the following briefing

24

deadlines and hearing date:

25

•

If plaintiff wishes to respond to Pharmacyclics’ motion to

26

quash, please do so by 4 PM ON SEPTEMBER 19, 2014.

27

Please limit the response to no more than TEN PAGES.

28

•

Any reply thereto is due by 4 PM ON SEPTEMBER 22,
2014. Please limit any reply to FIVE PAGES.

1
2

•

Hearing on the motion to quash is set for 8 AM ON
SEPTEMBER 24, 2014.

3
4

IT IS SO ORDERED.

5
6

Dated: September 16, 2014.

WILLIAM ALSUP
UNITED STATES DISTRICT JUDGE

7
8
9

11
For the Northern District of California

United States District Court

10

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
2